Project: OvA (Office versus Ambulatory Blood Pressure : an European Study).
- project duration
- 01-JUN-99 – 31-AUG-00
- OvA is a 10.000 patient-year follow-up study of treated essential hypertension (n=2242), who at yearly intervals undergo Office (OBP) and Ambulatory (ABP) blood pressure measurements. In a substudy, morbidity will be studied according to genetic polymorphisms (haptoglobin (HP), ACE-D/I polymorphisms), to test the hypothesis whether HP 2-2 and DD-ACE show a higher incidence in CV morbidity.